Crossmark

A Randomized Phase III Trial of Complete Mesocolic Excision Compared with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-in trial)

Crossref DOI link: https://doi.org/10.1245/s10434-023-14664-0

Published Online: 2023-12-12

Published Print: 2024-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Degiuli, Maurizio

Aguilar, Aridai H. Resendiz

Solej, Mario

Azzolina, Danila

Marchiori, Giulia

Corcione, Francesco

Bracale, Umberto

Peltrini, Roberto

Di Nuzzo, Maria M.

Baldazzi, Gianandrea

Cassini, Diletta

Sica, Giuseppe S.

Pirozzi, Brunella

Muratore, Andrea

Calabrò, Marcello

Jovine, Elio

Lombardi, Raffaele

Anania, Gabriele

Chiozza, Matteo

Petz, Wanda

Pizzini, Paolo

Persiani, Roberto

Biondi, Alberto

Reddavid, Rossella https://orcid.org/0000-0003-0603-9953
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04871399 at ClinicalTrials.gov

Documents that mention this clinical trial

A Randomized Phase III Trial of Complete Mesocolic Excision Compared with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-in trial)
https://doi.org/10.1245/s10434-023-14664-0
Funding

Funding for this research was provided by:

Università degli Studi di Torino (SOLM_RILO_18_01)

Università degli Studi di Torino
License Information

Text and Data Mining valid from 2023-12-12

Version of Record valid from 2023-12-12
More Information

Article History

Received: 1 September 2023

Accepted: 12 November 2023

First Online: 12 December 2023

DISCLOSURE

: There are no conflicts of interest.

Document is current

Any future updates will be listed below